Hikma
ADRIAMYCIN
Manufacturer:
Hikma
Name:
ADRIAMYCIN
HCPCS Code Descriptor:
Injection, doxorubicin hydrochloride, 10 mg
Category:
J Code
HCPCS:
J9000
NDC(s):
00069-3030-20, 00069-3031-20, 00069-3032-20, 00069-3034-20, 00069-4004-05, 00069-4015-10, 00069-4026-25, 00069-4037-01, 70860-0208-51, 70860-0208-25, 67457-0436-50, 63323-0883-05, 63323-0883-10, 63323-0883-30, 63323-0101-61, 62756-0826-40, 62756-0827-40, 45963-0733-60, 45963-0733-68, 45963-0733-55, 45963-0733-57, 25021-0207-51, 25021-0207-05, 25021-0207-25, 16714-0001-01, 00143-9277-01, 00143-9093-01, 00143-9089-01, 00143-9090-01, 00143-9091-01, 00143-9092-01, 00143-9084-01, 00143-9085-01, 00143-9086-01, 00143-9087-01, 00143-9088-01
Primary Type:
Oncology
Generic Status:
Multi-Source
Route of Administration:
Intravenous
About:
ADRIAMYCIN is an Oncology drug manufactured by Hikma and administered via the Intravenous route of administration. The J Code: J9000 is aligned to the drug ADRIAMYCIN.